PolyPid (PYPD) Earnings Date & Reports

A.I. Advisor

published Earnings

PYPD is expected to report earnings to fall 12.00% to -110 cents per share on November 06

Q3'24

Est.

$-1.10

Q2'24

Beat

by $0.05

Q1'24

Beat

by $2.78

Q4'23

Missed

by $0.39

Q3'23

Beat

by $7.56

The last earnings report on August 14 showed earnings per share of -125 cents, beating the estimate of -129 cents. With 6.42K shares outstanding, the current market capitalization sits at 24.63M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com